AUCTA PHARMACEUTICALS
Live / Allowed — Notice of allowance issued (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 Dec 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99564323
- Mark type
- Word mark
- Filed
- 23 Dec 2025
- Published for opposition
- 26 May 2026
- Attorney of record
- Christopher D Olszyk, Jr.
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of seizures in epilepsy, mood changes in bipolar disorders and depression and lesion reduction in neurofibromatosis and agents in the nature of drug delivery agents in the form of liquids, extended-release oral solids, inhalation and topical formulations that facilitate the delivery of pharmaceutical preparations.
Owner
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
- Aucta Pharmaceuticals, Inc., Piscataway, NJ, US
Prosecution history
- 21 Jul 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 May 2026 — PUBLISHED FOR OPPOSITION
- 20 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Apr 2026 — ASSIGNED TO EXAMINER
- 23 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 23 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Dec 2025 — NEW APPLICATION ENTERED